Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Year end tax loss selling and delays will all be over in January. I am waiting for 10 or below to purchase another 20,000 for a quick rise to $1 in 2019.
And the court date for debt resolution was in July before it was delayed to January. Nobody but the judge can control court delays.
You might find that there is a negative effect on the share price of the parent company of Leafly for being so desperate as to put out an article about a faked study of a competitors product.
With the Monday FDA declaration that CBD is mostly not legal to sell, there is a rule that anything that has been sold on the open market as a food or a supplement is allowed. I am hopeful that this rule will allow Diamond to continue to sell its current products without specific FDA approval for each. Going forward, any new product introductions may require approval. It was very forward thinking of Dr. Goulding to introduce the large number of products last year.
This study is a farce that could never be published in a real peer-reviewed research journal. The source is vague with no purchase dates or lot numbers- could be contaminated by the shadowy person who supplied it, there are no controls and most unbelievable is that the amount of the contaminants are not given!!! Could be 1 part per quadrillion. I completely lost my confidence in Leafly and the company who provides it.
That said, analytical data should be provided by vendors as Diamond provides on its web site. I purchased Relax gummies because of the melatonin because I wanted a sleep aid.
Summary judgement for dismissal of debt is likely- have you read the details of the court case that Cashcollections has kindly posted here several times from pacer?
Yes, get in cheap this week and multiply your returns in 2019.
I tried to acquire another 20000 Friday at .10, it never got that low. I will be watching this week to get them before January.
The FDA has high standards for purity and composition of active chemicals, called analytical fingerprint. It is very good to know that Dr. Goulding and the CEO have been preparing for FDA approval for some time. They will be ahead of competition in brand recognition as well as FDA approval. Go back and read POTN press releases more closely if you didn't understand this.
I agree that year end selling pressure will be gone in 2019, resulting in a slow but steady rise. With expected news about revenue increases and uplisting, there will be surges in share price. I and others will be buying into the new year when and if the gift of buying POTN around .10 happens.
I am hoping to see 7 to 8 million for fourth Q based on company PRs about trade show sales and new venues.
Blowout 4Q 2018 revenues will include the surge in Internet-based sales, holiday mall kiosk sales, 400 new orders at the latest Vegas trade show in July, new customer orders at the International trade show, and surge in medipets orders.
FALSE CLAIMS based on a bogus, uncontrolled study of another brand. Already refuted a while back by the CEO. Provide a link next time. Diamond uses independent CRO testing to ensure purity and integrity of their products. These Contract Research Organizations are used by big Pharmas to report product integrity to the FDA for drug approval and clinical trials.
They will retire shares, why would you expect them not to? IMO the court case has to be resolved first which will determine how many shares they owe to an investor of a former company in the distant past (according to a 2018 quarterly report they expect to win the case and owe little to no shares).
In spite of the current risks and small market cap, the daily trading volume of POTN is amazing, and this shows high interest. For these reasons, I believe this will rapidly become a dollar stock in first quarter 2019 and I am well positioned to benefit.
You are correct in that POTN has not met milestones by the approximate dates thrown out in PRs. But they meet the milestones eventually as stated. In January they will finally be free of the former company financially and we can look forward to reliable audited financials from a company listed on OTCQB and SEC registered.
I had planned to purchase 20000 in the low 10s but it held up too well. I will be watching over the next weeks.
POTN is the only green on my watchlist today also, and my watchlist is long and diverse.
The next catalyst will be earnings or debt resolution - hopefully- which wont be until January or Feb as I see it. Looks like they dropped monthly earnings reports.
Completely agree. The stress from the horrible state of the markets and political unrest will drive people to buy more CBD if anything. I have seen small cap, under the radar stocks do well in bear markets many times. We should be back to FOMO on CBD stocks in 2019. The trick is to get in BEFORE analysts to get the biggest fold returns.
Not talking institutional money yet, this is still very small cap and has much room to run up before then. My brokers at Schwab are putting it into personal accounts. Someday when and if it gets to the Nasdaq and gets into an ETF, it will be huge. If Hagen is good enough to make it there. IMO it can get to $5 before that best case, $2 for sure.
There is risk in owning POTN shares, of course. But- their daily volume is very high relative to other similar equities, their products are high quality (personal experience), the market is HUGE and they have an established presence.
And 2019 is the YEAR of CBD!!! Even my research institute is starting trials and physicians that I work with are writing reviews about it. And a clinical trial showed no abuse potential.
Everything takes longer than expected, always. You cant make real money unless you have a flexible time horizon. And apparently you don't know a single person taking pharmaceuticals with side effects for anxiety, pain or insomnia? You missed the memo that the market for CBD is HUGE HUGE HUGE?
2019 is the YEAR Of CBD. IMO retail stocks that are well positioned will benefit first, and we will see increases in revenues for POTN. Market conditions will not affect CBD sales, and POTN and others like CVSI with revenues will increase in value by February as investors pile in rather than miss out. The broader market and tech in particular will underperform and defensive stocks will do well.
How quickly everyone forgets the huge online and trade show sales that will be growing along with storefronts and mall kiosk sales. It's impossible to predict when the political craziness will end, but as soon as we get 4th quarter numbers and January debt resolution that will be background noise for the CBD sector.
Neither market sentiment (almost the worst I have seen) or recession will slow CBD sales. Diamond is extremely well positioned. The P will catch up with the E within months. I am buying here. Buy low sell high.
1st Q 2019 will include Mall Kiosk revs from Christmas as well as more shipments to stores, not to mention the huge increase in awareness of CBD.
To declare stalling revenues goes completely against the facts. Each quarter this year has been at least double last year revs, and we have not seen 4th quarter yet which will include orders mentioned in below PR:
https://www.potnetworkholding.com/media/press/potnetwork-holdings-inc-books-over-400-new-orders-2018-premiere-trade-show-asd-market
I have said this before, but we have had a 6 month delay due to accounting delays. I expect POTN to be past that in 2019, so the share price should be rising as PE usually reflects forward earnings.
Year end tax-loss selling and uncertainty about world markets might hold the share price down until Jan 2, and this is a great buying oppotunity for a very rapid 5-fold return. January into the next year I expect CBD stocks to fly. The risk for POTN will disappear with 4th Q earnings and debt resolution. The court date for a judge to rule to abolish debt by summary judgement is in January. FAANG stocks will be under even more pressure as the truth comes out daily about how they have sold user data for profit to each other. Smart investors will be looking for high-revenue stocks in a sector that will grow 5-fold over the next few years and not be affected by recession- CBD.
Just look at the BUDZ chart for 2016- 2017 with no revenues. If traders and investors looking for the "next big thing" get out of FAANG and get into CBD, $7 is quite possible for 2019.
Agree, but we already knew the financials of Sign and Drive were a mess. Maybe now it will finally be in the past and keep in mind the lawsuit is to be resolved in January. Share price has a lot of room to increase based on potential earnings.
The strongest and first catalyst will be 4th Q revenues IMO, hopefully mid January, and 2018 audited earnings.
I hope NOT unless the offer is at LEAST $5 per share
I am laughing to see that we typed the same thing at the same time, great minds again lol.
In January a few weeks from now we get Q4 and full year 2018 revs, resolution of debt in court- company has stated they expect summary judgement, uplist application. Forward thinking investors are buying now.
The legalization of hemp has ALREADY affected my city in Louisiana, stores are announcing sales of CBD beverages today because of it. Diamond is poised to make a BOATLOAD of money immediately if they can keep up with inventory. Let's hope blockchain is in place helping with inventory and orders and audits are completed more rapidly also.
Thanks Nate, that clarifies the reason for the delay which is not a big deal to me. That said, I really hope to see some new revenue numbers before Jan.
We should get new about uplisting by Monday based on the date of filing, right? Any news could double the shareprice- like Kali, wow! CEO Hagen, some revenue numbers SURE would be nice.
Power hour- hanging on to the gains. Have the number of outstanding shares gone down as listed on the OTC site? Here is the link, it wont let me copy and paste.
https://www.otcmarkets.com/stock/POTN/security